Meytal  Landau

Meytal Landau

Education/ Resume:

2020-Present       Visiting Group Leader, The European Molecular Biology Laboratory (EMBL), Hamburg, Germany.

2019-present        Associate Professor, The Faculty of Biology at the Technion – Israel Institute of Technology.

read more
Research Summary

Our lab pioneered the atomic-level analysis of structure-function relationships in bacterial amyloids and published the first structures of bacterial amyloid fibrils involved in cytotoxicity, antibacterial activity and biofilm structuring. In particular, the discovery of a novel class of cross-α amyloid fibrils of toxic peptides presented novel protein architectures, offered drug targets and leads, and opened a fresh perspective to study amyloid-related toxicity.

read more
Awards:

2020      Daniel Shiran Memorial Prize
2020      Hestrin Prize of the Israel Society for Biochemistry and Molecular Biology
2019      Juludan Research Prize

read more
Key Publications:
  • Landau, S.J. Fleishman and N. Ben-Tal. A Putative mechanism for down-regulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Structure 12: 2265-75, 2004.
  • Landau, I. Mayrose, Y. Rosenberg, F. Glaser, E. Martz, T. Pupko and N. Ben-Tal. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res 33: W299-W302, 2005.
  • Landau and N. Zisapel. The low affinity binding of melatonin to calmodulin: use of computational methods to explain its physiological relevance. Melatonin: from molecules to therapy, S.R. Pandi-Perumal and D.P. Cardinali. Hauppauge, NY: Nova Science Publishers, Inc. 2006.
read more
Recent Publications:
        • E. Tayeb-Fligelman*, O. Tabachnikov*, A. Moshe*, O. Goldshmidt-Tran, M.R. Sawaya, N. Coquelle, J-P. Colletier, and M. Landau. The Cytotoxic Staphylococcus aureus PSMα3 Reveals a Cross-α Amyloid-like Fibril. Science 355(6327): 831-833; 2017
read more
Open Positions

Our lab is looking for highly motivated Master and Ph.D. candidates who are interested in research integrating biophysical, biochemical, biological and computational methods for applications in drug development, biomedicine and nanotechnology.

read more
Also available to you on social media